Document:

EX-10.8

 Exhibit 10.8 

Employment Agreement 
 This Employment Agreement
(“Agreement”) is entered into effective as of February 15th, 2016, by and between MeiraGTx LLC (“Meira”), a Delaware limited liability company, and its parent MeiraGTx Limited
and subsidiaries (together, the “Company” or “MeiraGTx”), and Richard Giroux (“Employee”). 
 In consideration of the mutual
promises and covenants set forth herein, and other good and valuable consideration, the sufficiency of which is hereby acknowledged, the Company and Employee hereby agree as follows: 

1. Position of Employment. Meira will employ the Employee in the position of Chief Operating Officer and Head of Corporate Development of Meira and, in
that position, Employee will report directly to the Chief Executive Officer of Meira. In the event of a conflict between this Agreement and any Company policies, procedures, and practices, the terms of this Agreement shall govern. Except as
disclosed on Exhibit 1, Employee shall not undertake, either as an owner, director, shareholder, employee, or otherwise, the performance of services for compensation (actual or expected) for any other entity without the express written consent of
the Chief Executive Officer (“CEO”) of Meira. 
 2. Term of Employment. Employee’s employment with Meira shall begin on
February 15th, 2016, and shall continue until February 15th, 2019. Unless Employee or Meira gives notice of non-renewal to the other party at least 90 days before the expiration of the 3-year initial term (or each 1- year successive term),
this Agreement and Employee’s employment shall be automatically renewed and extended for additional 1-year periods. During a term, Employee’s employment may be terminated only in accordance
with Section 4 of this Agreement. 
 3. Compensation and Benefits. 

A. Base Salary. Employee shall initially be paid a base salary of $320,000 in cash annually by Meira, to be paid in accordance with
Meira’s regular payroll policies but no less frequently than twice per month (“Base Salary”). Employee’s Base Salary shall be increased to $400,000 in cash annually as of the first day of the first payroll period following when
the Company raises a total of $25 million in debt or equity, or a combination thereof, in one or more private placements (including any debt or equity already raised prior to the time of this Agreement). Employee’s Base Salary shall be
increased to $495,000 in cash annually as of the first day of the first payroll period following the earlier of (i) the date a registration statement for a class of the Company’s securities becomes effective; or (ii) the date of a
Change in Control of Meira or the Company (as defined in Section 5); or (iii) the date when the Company raises a total of $75 million in debt or equity, in one or more private placements or strategic collaborations or corporate
partnerships with another company (including any debt or equity already raised prior to the time of this Agreement). In addition, Employee’s Base Salary shall be reviewed annually or periodically in accordance with Meira’s normal
compensation review cycle, but any increase above the amounts herein specified shall be in the sole discretion of Meira management, and nothing herein shall be deemed to require any such increase other than as set forth above; provided, however,
that Employee’s Base Salary shall not be reduced. 

 B. Bonuses. 

i. Annual Bonus. Employee’s Annual Guaranteed Cash Bonus from Meira shall be 100% of Employee’s Base Salary in effect at the
time of payment. It shall be paid by January 15 of the following year. 
 ii. Performance Bonus. Employee’s Annual
Performance Cash Bonus from Meira shall be determined by the CEO of Meira and shall be targeted at no less than 50% of salary. It shall be paid by January 15 of the following year. (For the avoidance of doubt, the Annual Performance Cash Bonus
is in addition to the Annual Guaranteed Cash bonus.) 
 iii. Annual Performance Grants of Restricted Stock. Employee shall be granted
restricted stock for each year by January 15 of the following year, in amounts as determined by the CEO of Meira and the Company. Each grant of restricted stock shall become fully vested and owned by Employee quarterly in 1/12 increments over 3
years from the date of grant. While the Company is private, any income taxes owed by Employee from the grant of restricted stock at time of vesting shall be paid by the Company. 

C. Equity Incentives: 
 i. The
Company shall grant to Employee, as soon as the Compensation Committee deems reasonable but no longer than 3 (three) months after the Company has raised not less than $70 million in debt or equity, or a combination thereof, in one or more
private placements or strategic collaborations with another company (including any debt or equity already raised prior to the time of this Agreement), fully vested and owned shares representing an additional 1.50 percent of the fully diluted
outstanding shares of the Company, where any income taxes owed by Employee shall be paid by the Company at time of grant. Employee agrees not to sell or transfer these shares for a period of 12 months from the date of their grant (“lock-up period”). 
 ii. The Company shall grant to Employee, as of the date of the earlier of
(i) the date a registration statement for a class of the Company’s securities become effective, or (ii) the date of a Change in Control (as defined in Section 5) of Meira or the Company, restricted stock representing an
additional 2.50 percent of the fully diluted outstanding shares of the Company at the time (in the case of an IPO, the 2.00 percent shall be as of immediately after the shares are issued and offered for the IPO). 1/3 of this grant shall
vest immediately and the remaining 2/3 shall vest quarterly in 1/8 increments over the next 2 years from the date of grant. The Company shall pay any income taxes owed by employee as a result of the grant at the time of vesting. 

  
 2 

 iii. The Company shall grant to Employee, as of the first day of the first payroll period after
Meira or the Company becomes partially or wholly publicly owned, or becomes a subsidiary or parent of an entity that is partially or wholly publicly owned, as a result one or more strategic collaborations (including but not limited to a merger or
acquisition): the equity incentives in both a. and b. of this section, where a. is: “fully vested and owned shares representing an additional 1.50 percent of the fully diluted outstanding shares of the Company, where any income taxes owed
by Employee shall be paid by the Company at time of grant. Employee agrees not to sell or transfer these shares for a period of 12 months from the date of their grant (“lock-up period”)”; and
where b. is: “restricted stock representing an additional 2.50 percent of the fully diluted outstanding shares of the Company at the time”, if sections a. and b. have not already been granted. 

D. Strategic Collaboration Bonus. The Company shall grant to Employee, as of the first day of the first payroll period after the Company
has completed a strategic collaboration with another company, a cash bonus, if such collaboration(s) results in upfront payments of any kind, including but not limited to cash, equity, research or collaboration upfront consideration for Meira (there
is no limit to the number of collaboration bonuses per annum). The cash bonus payment shall be at the discretion of the CEO and Compensation Committee provided, however, that such bonus shall not be less than 1.0% of the total upfront payments
(including any cash, equity or other upfront consideration) received by Meira in any collaboration. 
 E. Incentive and Deferred
Compensation. Employee shall be eligible to participate in all incentive and deferred compensation programs available to executive officers of Meira from time to time on the same terms and conditions and extent that such programs are made
available to other such executives or officers of Meira. 
 F. Employee Benefits. Employee shall be eligible to participate in all
employee benefit plans, policies, programs, or perquisites made available to employees of Meira generally or to executive officers of Meira, including any broad-based or executive stock option and stock purchase plans. The terms and conditions of
Employee’s participation in Meira’s employee benefit plans, policies, programs, or perquisites shall be governed by the terms and conditions or practices of each such plan, policy, or program, or perquisite. 

4. Termination of Employment. Employee’s employment with Meira may be terminated, prior to the expiration of the term of this Agreement, in
accordance with the following provision: 
 A. Termination by Employee Without Good Reason. The Employee may terminate Employee’s
employment without Good Reason (as defined in Section 4.D. of this Agreement) at any time by giving three months’ notice to the CEO of Meira, except that such notice is not required if the Good Reason is as defined in Section 4.D.(vi)
or (vii). 
 Upon termination by the Employee of Employee’s employment without Good Reason under this Section 4.A., Employee shall
(i) be entitled to his Base Salary, Guaranteed Cash Bonuses, and Performance Cash Bonuses targeted at no less than 50% of his Base Salary as if his employment had continued for a period of an additional 12 months from termination, (ii) be
entitled to employee benefits and post-employment employee benefits and conversion rights in accordance with the terms and conditions of the plans, policies, programs, or perquisites in which he participates, (iii) be entitled to the incentive
and 

  
 3 

 
deferred compensation incentive rights in accordance with the terms and conditions of the incentive and deferred compensation plans in which he participates, (iv) be entitled to keep any
restricted stock and equity incentive awards granted under this Agreement or otherwise (including under the Performance Based Equity Incentive Agreement) that have been triggered and are vested as of the termination date, and (v) forfeit any
restricted stock or equity incentive awards that are unvested on the date of termination. 
 B. Termination By Death or Disability.
Employee’s employment shall terminate upon the Employee’s death or disability, except as prohibited by law. For purposes of this Section 4.B., disability means the inability to perform the duties of his position for a period
lasting more than 180 days due to any medical condition. 
 Upon termination of Employee’s employment upon the Employee’s death or
disability under this Section 4.B., Employee or his estate or beneficiary or beneficiaries shall (i) be entitled to his Base Salary, Guaranteed Cash Bonuses, and Performance Cash Bonuses targeted at no less than 50% of his Base Salary as
if his employment had continued for a period of an additional 12 months from termination, (ii) be entitled to employee benefits and post-employment employee benefits and conversion rights in accordance with the terms and conditions of the
plans, policies, programs, or perquisites in which he participates, (iii) be entitled to the incentive and deferred compensation incentive rights in accordance with the terms and conditions of the incentive and deferred compensation plans in
which he participates, (iv) be entitled to keep any restricted stock and equity incentive awards granted under this Agreement or otherwise (including under the Performance Based Equity Incentive Agreement) that have been triggered and are
vested as of the termination date, and (v) forfeit any restricted stock or equity incentive awards that are unvested on the date of termination. 

C. Termination by Meira for any reason other than Cause. Meira may terminate Employee’s employment for any reason other than Cause
(as defined in Section 4.E. of this Agreement), including but not limited to termination because of a Change of Control or expiration of a term. Meira may terminate Employee’s employment at any time for any reason other than Cause by
giving three months’ notice to the Employee. During the notice period, Employee shall remain in active employment or non-active employment as Meira may decide; provided, that Meira or the Employee may
choose instead for Meira to give Employee severance pay in the amount of the remaining notice period in lieu of continued employment, to be paid within 30 days of Employee’s last date of actual employment. 

Upon termination by Meira of Employee’s employment for any reason other than Cause under this Section 4.C., Employee shall
(i) be entitled to his Base Salary, Guaranteed Cash Bonuses, and Performance Cash Bonuses targeted at no less than 50% of Base Salary as if his employment had continued for the greater of a period of 24 months from termination and such amount
of time as remains until the end of the then current term under Section 2 above, including pro-rated Guaranteed Cash Bonuses and Performance Cash Bonuses targeted at 50% of Base Salary for any stub
periods (for example, if Employee were terminated for any reason other than Cause effective 7/15/17, Employee would be paid his Base Salary through 7/15/19, Employee’s Guaranteed Cash Bonuses and Performance Cash Bonuses targeted at 50% of Base
Salary for calendar year 2017 on 1/15/18 and for 

  
 4 

 
calendar year 2018 on 1/15/19, and 6.5/12 of Employee’s Guaranteed Cash Bonus and Performance Cash Bonus targeted at no less than 50% of Base Salary for 2019 on 1/15/20), to be paid on the
originally scheduled dates, (ii) be entitled to employee benefits and post-employment employee benefits and conversion rights in accordance with the terms and conditions of the plans, policies, programs, or perquisites in which he participates
for a period of 24 months following the end of the current term (i.e., until the end of the term and then another 24 months) of the Agreement, (iii) be entitled to the incentive and deferred compensation incentive rights in accordance with the
terms and conditions of the incentive and deferred compensation plans in which he participates; provided, however, that Employees shall be deemed fully vested in any incentive and deferred compensation awards under such plans upon a termination,
(iv) be entitled to keep any restricted stock and equity incentive awards granted under this Agreement or otherwise that have been triggered and are vested as of the termination date, (v) be deemed upon termination fully vested in and
owning any restricted stock and equity incentive awards granted under this Agreement or otherwise (including under the Performance Based Equity Incentive Agreement) that are unvested on the date of termination, (vi) be granted upon and as of
the termination date fully vested and owned shares for all of the restricted stock not yet granted but provided for under Section 3-C.ii. or otherwise (including under the Performance Based Equity
Incentive Agreement) as if all conditions in those sections were met, and (vii) be paid, within 30 days of termination, a cash termination fee equivalent to 1.00% of the Market Value (as defined below) of the Company shares on average during
the 90-trading day period prior to the termination where any taxes owed by Employee as a result of the termination fee are to be paid by the Company (“Market Value” shall mean (a) the number
computed by multiplying (i) the aggregate worldwide number of shares of the Company’s voting and non-voting common equity (including stock held by employees and affiliates) by (ii) the average
of the last closing prices of the Company’s common equity in the principal market for such common equity; and (b) the “Market Value” shall be adjusted on a pro rata basis for any mechanical adjustments in the Company’s
equity resulting from forward or reverse stock splits), All of these amounts shall be paid regardless of whether Employee obtains subsequent employment. 

D. Termination by the Employee for Good Reason. The Employee may terminate Employee’s employment at any time for Good Reason. For
purposes of this Section 4.D., “Good Reason” shall mean a termination of employment by the Employee for one or more of the following reasons: (i) any material diminution of the Employees’ title, duties, work
responsibilities, authority, or status, or the assignment of duties that would typically be performed by a Chief Operating Officer and/or Head of Corporate Development to someone other than Employee; (ii) a material negative change in
Employee’s reporting structure such that Employee no longer reports directly to the CEO, or such that any employee or position that previously reported directly to Employee no longer reports directly to Employee; (iii) a Change in Control
of Meira or the Company (as defined in Section 5); (iv) a reduction at any time in the Employee’s then current Base Salary; (v) a change in Employee’s principal place of employment to a location more than 15 miles from Manhattan,
New York; (vi) a breach by Meira or the Company of this Agreement, which breach is not remedied or corrected within 30 days after notice from the Employee to the Company of such breach; (vii) Meira’s or the Company’s insistence
that Employee perform or condone any illegal conduct; or (viii) a hostile or abusive work environment or 

  
 5 

 
harassment (regardless of whether based on a statutorily protected characteristic such as race, age, religion, sex, sexual orientation, or the like, and regardless of whether such hostile or
abusive work environment or harassment is severe or pervasive), including but not limited to verbal abuse such as the use of derogatory remarks, insults, and epithets; verbal, non-verbal, or physical conduct
of a threatening, intimidating, or humiliating nature; the sabotage or undermining of Employee’s work performance; bullying; or retaliation for a good faith complaint that a hostile or abusive work environment or harassment exists. 

Upon termination by the Employee of Employee’s employment for Good Reason under this Section 4.D., Employee shall be entitled to the
same rights and payments as if Employee’s employment had been terminated by Meira for any reason other than Cause pursuant to Section 4.C. of this Agreement. 

E. Termination by Meira For Cause. Meira may terminate Employee’s employment hereunder for Cause. For purposes of this
Section 4.E., Cause means (a) conviction of a felony involving moral turpitude; (b) embezzlement; or (c) intentional and willful misconduct that may subject Meira to criminal liability, which misconduct is not remedied,
corrected, and/or cured within 30 days after written notice from Meira to Employee of such breach, if remediable, correctable, or curable. 

Upon termination by Meira of Employee’s employment for Cause under this Section 4.E., Employee shall (i) be entitled to his Base
Salary through the date of termination, (ii) be entitled to employee benefits and post-employment employee benefits and conversion rights in accordance with the terms and conditions of the plans, policies, programs, or perquisites in which he
participates, (iii) be entitled to the incentive and deferred compensation Incentive rights in accordance with the terms and conditions of the incentive and deferred compensation plans in which he participates, (iv) be entitled to keep any
restricted stock or equity incentive awards granted under this Agreement or otherwise (including under the Performance Based Equity Incentive Agreement) that have been triggered and are vested as of the termination date, and (v) forfeit any
restricted stock or equity incentive awards that are unvested on the date of termination. 
 5. Change of Control. For purposes of this Agreement,
“Change in Control” shall mean: (i) the sale or other disposition of all or substantially all of the assets of Meira or the Company; (ii) any sale or exchange of the capital stock of the Company by the stockholders of the Company
in one transaction or series of related transactions where more than fifty percent (50%) of the outstanding voting power of the Company is acquired by a person or entity or group of related persons or entities; (iii) any reorganization,
consolidation or merger of the Company where the outstanding voting securities of the Company immediately before the transaction represent or are converted into less than fifty percent (50%) of the outstanding voting power of the surviving entity
(or its parent corporation) immediately after the transaction; or (iv) the consummation of the acquisition of fifty- one percent (51%) or more of the outstanding stock of the Company pursuant to a tender offer validly made under any federal or
state law (other than a tender offer by the Company). 

  
 6 

 6. Confidentiality. Employee agrees that at all times during Employee’s employment and following the
conclusion of Employee’s employment hereunder, whether voluntary or involuntary, Employee will hold in strictest confidence and not disclose Confidential Information (as defined below) to anyone who is not also an employee of Meira or the
Company or to any employee of Meira or the Company who does not also have access to such Confidential Information, other than to an attorney to obtain legal advice, without express written authorization of the CEO of Meira. For purposes of this
Section 6, Confidential Information means any trade secrets or Company proprietary information, including but not limited to manufacturing techniques, processes, formulas, inventions, experimental developments, research projects, operating
methods, cost, pricing, financial data, business plans and proposals, data and information Meira or the Company receives in confidence from any other party, or any other secret or confidential matters of the Company. Additionally, Employee will not
use any Confidential Information for Employee’s own benefit or to the detriment of Meira or the Company during Employee’s employment or thereafter. Employee also certifies that employment with Meira does not and will not breach any
agreement or duty that Employee has to anyone concerning confidential information belonging to others. 
 7. Expenses. Meira shall pay or reimburse
Employee for any expenses reasonably incurred by Employee in furtherance of Employee’s duties hereunder, including expenses for entertainment, travel, meals and hotel accommodations, upon submission by Employee of expense reports in accordance
with such rules and policies relating thereto as Meira may from time to time adopt. 
 8. General Provisions. 

A. Notices. All notices and other communications required or permitted by this Agreement to be delivered to Meira or the Company or
Employee to the other party shall be delivered in writing to the address shown below, either personally, by electronic mail, by facsimile transmission, or by registered, certified, or express mail, return receipt requested, postage prepaid, to the
address for such party specified below or to such other address as the party may from time to time advise the other party in writing in the same manner as set forth in this Section 8.A., and shall be deemed given and received as of actual
personal delivery, on the first business day after the date of delivery shown on any such electronic mail or facsimile transmission or upon the date or actual receipt shown on any return receipt if registered, certified, or express mail is used, as
the case may be. 
 Company: 

Alexandria Forbes, CEO 
 MeiraGTx 
 450 East 29th Street, 15th Floor 
 New York, NY 10016 

zandy@meiragtx.com 

  
 7 

 Employee: 

Richard Giroux 
 69 Perry Street,
#5 
 New York, NY, 10014 

rich@meiragtx.com 
 646-932-0208 
 B. Amendments and Termination; Entire Agreement.
This Agreement may not be amended or terminated except by a writing executed by all of the parties hereto. This Agreement, along with the Performance Based Equity Incentive Agreement between the Company and Meira and Employee, constitutes the
entire agreement of the Company and Meira and Employee relating to the subject matter hereof and supersedes all prior oral and written understandings and agreements relating to such subject matter. 

C. Successors and Assigns. The rights and obligations of the parties hereunder are not assignable to another person without prior
written consent; provided, however, that Meira’s and the Company’s obligations hereunder shall be binding upon their successors and assigns. 

D. Severability; Provisions Subject to Applicable Law. All provisions of this Agreement shall be applicable only to the extent that they
do not violate any applicable law, and are intended to be limited to the extent necessary so that they will not render this Agreement invalid, illegal or unenforceable under any applicable law. If any provision of this Agreement or any application
thereof shall be held to be invalid, illegal or unenforceable, the validity, legality and enforceability of other provisions of this Agreement or of any other application of such provision shall in no way be affected thereby. 

E. Waiver of Rights. No waiver by Meira, the Company or Employee of a right or remedy hereunder shall be deemed to be a waiver of any
other right or remedy or of any subsequent right or remedy of the same kind. 
 F. Definitions; Headings; Number. A term defined in
any part of this Agreement shall have the defined meaning wherever such term is used herein. The headings contained in this Agreement are for reference purposes only and shall not affect in any manner the meaning or interpretation of this Agreement.
Where appropriate to the context of this Agreement, use of the singular shall be deemed also to refer to the plural, and use of the plural to the singular. 

G. Counterparts. This Agreement may be executed in separate counterparts and by facsimile, electronic, or pdf, each of which shall be
deemed an original but both of which taken together shall constitute but one and the same instrument. 
 H. Governing Laws; Forum; Legal
Fees. This Agreement shall be governed by, construed, and enforced in accordance with the laws of the State of New York. The parties hereto further agree that any action brought to enforce any right or obligation under this Agreement shall be
subject to the exclusive jurisdiction of the state or federal courts of the State of New York. If Employee brings suit against Meira and/or the Company arising from or related to this Agreement, Meira and the Company shall pay Employee’s
attorneys’ fees and costs incurred in such suit on a monthly basis. 

  
 8 

 IN WITNESS WHEREOF, Meira, the Company and Employee have executed and delivered this Agreement as of the date
first written above. 
  

	
	MEIRAGTX
	/s/ Alexandria Forbes Date: February 24th, 2016
	Alexandria Forbes
	CEO, MeiraGTx
	
	MEIRAGTX
	
	/s/ Tom Shenk Date: February 23rd, 2016
	Tom Shenk
	Chairman of the Board, MeiraGTx
	
	/s/ Keith Harris Date: February 24th, 2016
	Keith Harris
	Chairman, Compensation Committee, MeiraGTx
	
	RICHARD GIROUX
	
	/s/ Richard Giroux Date: February 17th, 2016
	Richard Giroux

  
 9 

 EXHIBIT 1 

The following outside business interests are disclosed pursuant to Section 1 of this Agreement: 

1. Aigle HC Partners I, LLC 
 2.
Aigle HC Partners II, LLC 
 3. Perry Consultants, LLC 

  
 10 

 EMPLOYMENT AGREEMENT AMENDMENT 

This Employment Agreement Amendment (the “Amendment”) is made as of May 28, 2018 (the “Amendment Date”) by
and among MeiraGTx Limited and MeiraGTx LLC (together, the “Company”) and Richard Giroux (the “Employee”). Except as set forth in this Amendment, capitalized terms used but not defined herein shall have the meanings
ascribed to them in the Employment Agreement (as defined below). 
 WITNESSETH 

WHEREAS, Employee previously entered into an employment agreement with the Company effective as of February 15, 2016 (the
“Employment Agreement”); and 
 WHEREAS, the Employee and the Company each desire to amend the terms of the Employment
Agreement as set forth in this Amendment. 
 NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are
hereby acknowledged, the Employee and the Company hereby agree to the following: 
  

	1.	Amendment to the Employment Agreement. Effective as of the Amendment Date, the Employment Agreement is hereby amended by adding a new Section 8.I as follows: 

I. Section 409A. 

i. The intent of the parties is that the payments and benefits under this Agreement comply with or be exempt from
Section 409A (“Section 409A”) of the Internal Revenue Code of 1986, as amended, and the regulations and guidance promulgated thereunder (the “Code”) and, accordingly, to the maximum extent permitted, this Agreement
shall be interpreted to be in compliance therewith. 
 ii. Notwithstanding anything in this Agreement to the contrary, any
compensation or benefits payable under this Agreement that is designated under this Agreement as payable upon Employee’s termination of employment shall be payable only upon Employee’s “separation from service” with the Company
within the meaning of Section 409A (a “Separation from Service”). 
 iii. Notwithstanding anything in this
Agreement to the contrary, if Employee is deemed by the Company at the time of Employee’s Separation from Service to be a “specified employee” for purposes of Section 409A, to the extent delayed commencement of any portion of the
benefits to which Employee is entitled under this Agreement is required in order to avoid a prohibited distribution under Section 409A, such portion of Employee’s benefits shall not be provided to Employee prior to the earlier of
(i) the expiration of the six-month period measured from the date of Employee’s Separation from Service with the Company or (ii) the date of Employee’s death. Upon the first business day
following the expiration of the applicable Section 409A period, all payments deferred pursuant to the preceding sentence shall be paid in a lump sum to Employee (or Employee’s estate or beneficiaries), and any remaining payments due to
Employee under this Agreement shall be paid as otherwise provided herein. 

 iv. To the extent that any reimbursements under this Agreement are subject to
Section 409A, any such reimbursements payable to Employee shall be paid to Employee no later than December 31 of the year following the year in which the expense was incurred; provided, that Employee submits Employee’s reimbursement
request promptly following the date the expense is incurred, the amount of expenses reimbursed in one year shall not affect the amount eligible for reimbursement in any subsequent year, other than medical expenses referred to in Section 105(b)
of the Code, and Employee’s right to reimbursement under this Agreement will not be subject to liquidation or exchange for another benefit. 

v. Except as otherwise permitted under Section 409A, no payment hereunder shall be accelerated or deferred unless such
acceleration or deferral would not result in additional tax or interest pursuant to Section 409A. 
  

	2.	No Other Amendment. Except as expressly set forth in this Amendment, the Employment Agreement shall remain unchanged and shall continue in full force and effect according to its terms. 

 

	3.	Entire Agreement. This Amendment, together with the Employment Agreement (to the extent not amended hereby), represents the entire agreement of the parties with respect to the subject matter hereof and shall
supersede any and all previous contracts, arrangements or understandings between the parties. 

 [signature page follows] 

 IN WITNESS WHEREOF, the Company and the Employee have executed this Amendment as of the date
first written above. 
  

			
	MEIRAGTX LIMITED

 
			
		
	By:	 	/s/ Alexandria Forbes
	Name:	 	 Alexandria Forbes

	Title:	 	CEO MEIRAGTX

 
			
	
	MEIRAGTX LLC

 
			
		
	By:	 	/s/ Alexandria Forbes
	Name:	 	Alexandria Forbes
	Title:	 	CEO MEIRAGTX

 
			
	
	EMPLOYEE
	/s/ Richard Giroux
	 Richard GirouxEX-10.9

 Exhibit 10.9 

Service Agreement 
 this agreement
made the 27th day of April 2015 
  

	BETWEEN:	

 (1) Athena Vision Limited (registered number 09348737) whose registered office is at C/O UCL Business
PLC The Network Building 97 Tottenham Court Road, London W1T 4TP (the “Company”) and 
 (2) Stuart Naylor of 40 Longfield Drive, Amersham,
Buckinghamshire HP6 5HE (the “Executive”). 
 WHEREAS: 

The Company wishes to employ the Executive and the Executive has agreed to serve the Company as Chief Executive Officer on the terms and conditions set out in
this Agreement. 
 IT IS AGREED: 
  

	1.	APPOINTMENT AND TERM 

 The Company shall employ the Executive and the Executive shall
serve the Company as Chief Executive Officer with a further role as Chief Development Officer with effect from April 27th, 2015. Either the Executive or the Company may terminate the employment at any time by giving to the other not less than 12
months’ notice in writing. 
  

	2.	DUTIES 

  

	2.1	During his employment hereunder the Executive shall: 

  

	 	(a)	

  

	 	(i)	perform functions consistent with his role as Chief Executive Officer and perform such other duties and exercise the powers and functions which from time to time may reasonably be assigned to or vested in him by the
Board of Directors of the Company (the “Board”) in relation to the Company and any Associated Company (as defined in clause 16 below) at such place or places both within and outside the United Kingdom as the Board shall determine;

  

	 	(ii)	(in his capacity as Chief Development Officer, research, develop and conceive of ways of using gene therapy in the diagnosis, treatment, management and/or prevention of conditions and diseases in humans and animals,

 (together the “Development Duties”); 

	 	(b)	during working hours devote the whole of his time, attention and ability to the Development Duties and shall faithfully and loyally serve the Company to the best of his ability and use his utmost endeavours to promote
its interests in all respects; 

  

	 	(c)	comply with all reasonable requests, instructions and regulations given or made by the Board (or by any one authorised by it) in relation to the Development Duties and promptly provide such explanations, information and
assistance as to his activities or the business of the Company as the Board may reasonably require; and 

  

	 	(d)	not engage in any activities which would detract from the proper performance of his duties hereunder, nor without the prior written consent of the Board in any capacity including as director, shareholder, principal,
consultant, agent, partner or employee of any other company, firm or person (save as the holder for investment of securities which do not exceed three per cent (3%) in nominal value of the share capital or stock of any class of any company quoted on
a recognised stock exchange) engage or be concerned or interested directly or indirectly in any other trade, business or occupation whatsoever. 

  

	2.2	Notwithstanding the provisions of clause 2.1 the Company shall: 

  

	 	(a)	have the right to require the Executive at any time to carry out such special projects or functions commensurate with his abilities as the Company shall in its absolute discretion determine; and 

 

	 	(b)	be under no obligation to assign to or vest in the Executive any powers, duties or functions or to provide any work for the Executive and may at any time suspend the Executive from the performance of any duties or
exclude him from any premises of the Company. During the period of any such suspension or exclusion the Executive will remain an employee of the Company and may not work (whether or not for remuneration) for any other organisation (whether or not a
competitor of the Company or any Associated Company) and the Company shall have the right to require the Executive not to speak to or otherwise communicate with any director or employee of the Company or any Associated Company or any person, firm or
company who at the date of such suspension or exclusion is a client or customer of the Company or any Associated Company. 

  

	2.3	The Executive agrees that the maximum weekly working time as set out in regulation 4 of the Working Time Regulations 1998 shall not apply in relation to his employment. This condition shall apply indefinitely subject to
the Executive’s right to withdraw his agreement to the exclusion of the maximum weekly working time on providing three months’ written notice. 

  

	3.	REMUNERATION 

  

	3.1	As remuneration for his services hereunder the Company shall pay to the Executive a salary at the rate of two hundred thousand pounds (£200,000) per annum (which shall be deemed to accrue from day to day) payable
in arrears by equal monthly instalments on the last day of each month such salary being inclusive of any fees to which the Executive may be entitled as a director of the Company or of any Associated Company. The said salary shall be reviewed by the
Board from time to time. While a review does not imply any entitlement to an increase, the salary payable to the Executive may be increased with effect from any such review date. 

  
 2 

	3.2	For the purposes of the Employment Rights Act 1996 and otherwise the Executive hereby consents to the deduction of any sums owing by him to the Company at any time from his salary or any other payment due from the
Company to the Executive and the Executive hereby also agrees to make any payment to the Company of any sums owed by him to the Company upon demand by the Company at any time. 

 

	4.	PENSION AND INSURANCE BENEFITS 

  

	4.1	Subject to the allowances set by HM Revenue and Customs from time to time, the Company shall contribute at a rate equivalent to 10% of the Executive’s basic monthly salary into a registered personal pension scheme
of the Executive’s choice. 

  

	4.2	As long as the Executive is employed by the Company, and conditional upon the Company being able to provide each of the benefits set out below, the Company shall pay premiums on behalf of the Executive up until the
Executive reaches the age of 65 or state pension age, whichever is the higher, to provide medical insurance, permanent health insurance and life assurance. The Company shall have the right to change its arrangements for or withdraw the provision of
such benefits as it sees fit providing always that it replaces such benefits with cover of substantial equivalence. 

  

	4.3	For the purposes of clause 4.2, participation in any such insurance scheme is: 

  

	 	(a)	on the basis that the Company can give no assurance that any claim made will be accepted by the insurers of such scheme; 

  

	 	(b)	on the basis that the Company shall not be required to take any steps to obtain the benefit of such scheme should the insurer either reject any claim and/or discontinue the payment of benefits at any time; and

  

	 	(c)	on the basis that the Company shall not be liable to pay any sums to or in respect of the Executive and/or his dependants unless the Company has received payment in full from the insurer. 

 

	4.4	The provision of the benefits at clause 4.2 shall not restrict the Company’s ability to terminate the Executive’s employment in accordance with clauses 1 or 12 of this Agreement for any reason including,
without limitation, because the Executive is incapacitated. 

  

	5.	BONUS 

  

	5.1	The Executive is entitled to be considered for an annual bonus and the Company may, in its absolute discretion, pay to the Executive a bonus of such amount, if any, as the Board may determine provided that:

  
 3 

	 	(a)	any such bonus may consist of or include securities and/or share options in the Company or any Group Company; and 

  

	 	(b)	if the Company makes a bonus payment to the Executive in respect of any bonus year, it shall not be obliged to make a bonus payment in any subsequent bonus year and the Executive agrees that he shall have no entitlement
to receive such a payment; and 

  

	 	(c)	no bonus shall be paid if before the date on which the Company usually pays bonuses: 

  

	 	(i)	notice of termination has been given by either party to the other; and/or 

  

	 	(ii)	the Executive’s employment under this Agreement is terminated for any reason; and/or 

  

	 	(iii)	the Company has instituted disciplinary proceedings against the Executive or the Executive is subject to an unexpired disciplinary warning. 

 

	6.	EXPENSES 

 The Company shall reimburse to the Executive all travelling, hotel,
entertainment and other expenses properly and reasonably incurred by him in the performance of his duties hereunder and properly claimed and vouched for (including production of appropriate receipts or other evidence) in accordance with the
Company’s expense reporting procedure in force from time to time. 
  

	7.	HOLIDAYS AND HOLIDAY PAY 

  

	7.1	In addition to the normal Bank and public holidays the Executive shall be entitled to 28 working days’ paid holiday during each calendar year to be taken at such time or times as may be agreed with the Board. The
Executive may not without the consent of the Board carry forward any unused part of his holiday entitlement to a subsequent calendar year. 

  

	7.2	For the calendar year during which the Executive’s employment hereunder commences or terminates he shall be entitled to such proportion of his annual holiday entitlement as the period of his employment in each such
year bears to one calendar year. Upon termination of his employment for whatever reason he shall if appropriate either be entitled to salary in lieu of any outstanding holiday entitlement or be required to pay to the Company any salary received in
respect of holiday taken in excess of his proportionate holiday entitlement. 

  

	8.	SICKNESS/INCAPACITY 

  

	8.1	If the Executive shall be prevented by illness, accident or other incapacity from properly performing his duties hereunder he shall report this fact forthwith to the Board and if he is so prevented for more than seven
consecutive days he shall if required by the Company provide an appropriate doctor’s certificate. 

  
 4 

	8.2	If the Executive shall be absent from his duties hereunder owing to illness, accident or other incapacity duly certified in accordance with the provisions of clause 8.1 he shall be paid his full remuneration for the
first ten days of such absence and thereafter subject to the provisions of clause 12 such remuneration as the Board shall in its discretion allow provided that there shall be deducted from such remuneration any Statutory Sick Pay or any social
security or other benefits payable to the Executive including any sums recoverable from a third party and any sums payable to the Executive under the permanent health insurance arrangement referred to in clause 4.1 above. 

 

	9.	CONFIDENTIAL INFORMATION 

  

	9.1	The Executive shall not at any time during the course of his employment nor at any time after its termination except for a purpose of the Company or any Associated Company directly or indirectly use or disclose trade
secrets or confidential information relating to the Company or any Associated Company or the Company’s or any Associated Company’s agents, customers, prospective customers or suppliers. 

 

	9.2	For the purposes of clause 9.1 confidential information shall include any information relating to the business and/or the financial affairs of the Company and/or any Associated Company and the Company’s and/or any
Associated Company’s agents, customers, prospective customers or suppliers and in particular shall include: 

  

	 	(a)	the business methods and information of the Company and any Associated Company (including prices charged, discounts given to customers or obtained from suppliers, product development, marketing and advertising
programmes, costings, budgets, turnover, sales targets or other financial information); 

  

	 	(b)	confidential details as to the design of the Company’s and any Associated Company’s products and Inventions or developments relating to future Inventions or products or details of its or their research
development programs or plans; 

  

	 	(c)	secret research, manufacturing or production processes and know-how employed by the Company and any Associated Company or its/their suppliers; 

 

	 	(d)	details and terms of the Company’s and any Associated Company’s agreements with suppliers and customers and lists and particulars of the Company’s and any Associated Company’s suppliers and customers
and the individual contacts at such suppliers and customers; 

  

	 	(e)	details of any promotions or future promotions or marketing or publicity exercises planned by the Company and any Associated Company; 

	 	(f)	details of any budgets or business plans of the Company and any Associated Company; and 

  

	 	(g)	any information which may affect the value of the business or the shares of the Company or any Associated Company, whether or not in the case of documents or other written materials or any materials in electronic format
they are or were marked as confidential and whether or not, in the case of other information, such information is identified or treated by the Company or any Associated Company as being confidential. 

  
 5 

	9.3	The Executive shall not be restrained from using or disclosing any confidential information which: 

  

	 	(a)	he is authorised to use or disclose by the Board; or 

  

	 	(b)	has entered the public domain unless it enters the public domain as a result of an unauthorised disclosure by the Executive or anyone else employed or engaged by the Company or any Associated Company; or

  

	 	(c)	he is required to disclose by law 

  

	9.4	The Executive shall not make copies of any document, memoranda, correspondence (including emails), computer disk, CD-ROM, memory stick, video tape or any similar matter (including
for the avoidance of doubt in any electronic format) or remove any such items from the premises of the Company or of any Associated Company other than in the proper performance of his duties under this Agreement except with the Board’s written
authority which authority will apply in that instance only. 

  

	10.	INTELLECTUAL PROPERTY 

  

	10.1	The parties acknowledge that the Executive is employed to create Inventions (alone or jointly) pursuant to his Development Duties in the course of his employment with the Company and that the Executive has a special
obligation to further the interests of the Company in relation to such Inventions. The Executive shall, promptly following creation, disclose to the Company all such Inventions and works embodying Company Intellectual Property. It is further
acknowledged that anything done by the Executive in furtherance of any program or development plan funded by the Company is intended to be Company Intellectual Property. 

 

	10.2	The Executive acknowledges that (except to the extent prohibited by or ineffective in law) all Company Intellectual Property and materials embodying them shall automatically belong to the Company as from creation for
the full term of those rights and (except to the extent prohibited by or ineffective in law), the Executive hereby assigns, by way of present and future assignment, any and all right, title and interest therein to the Company. 

 

	10.3	To the extent that any Company Intellectual Property does not vest in the Company automatically pursuant to clause 10.2 (and except to the extent prohibited by or ineffective in law), the Executive holds such property
on trust for the Company and hereby grants to the Company an exclusive, royalty free licence to use such property in its discretion until such Company Intellectual Property fully vests in the Company. 

  
 6 

	10.4	To the extent that any Inventions created by the Executive (whether alone or jointly) pursuant to his Development Duties at any time during the course of his employment are prohibited by or prevented in law from
automatically vesting with the Company pursuant to clause 10.2, the Executive shall, immediately upon creation of such rights, grant the Company a right of first refusal, in writing, to acquire them on arm’s length terms to be agreed between
the parties. If the parties cannot agree on such terms within 30 days of the Company receiving the offer, the Company shall refer the dispute to an arbitrator who shall be appointed by the President of the Institute of Chartered Accountants in
England and Wales. The arbitrator’s decision shall be final and binding on the parties and the costs of arbitration shall be borne equally by the parties. 

  

	10.5	The Executive agrees: 

  

	 	(a)	to use reasonable endeavours to execute all such documents, both during and after the Appointment, as the Company may require to vest in the Company all right, title and interest in and to the Company Intellectual
Property at the reasonable expense of the Company: 

  

	 	(b)	to use reasonable endeavours to, provide all such information and assistance and do all such further things as the Company may require to enable it to protect, maintain and exploit the Company Intellectual Property to
the best advantage, at the reasonable expense of the Company, including (without limitation), at the Company’s request, applying throughout the world for the protection of Inventions resulting from the Executive’s Development Duties;

  

	 	(c)	to use reasonable endeavours to assist the Company in applying for the registration of any registrable Company Intellectual Property, to enable it to enforce the Company Intellectual Property against third parties and
to defend claims for infringement of third party Intellectual Property Rights by Company Intellectual Property at the reasonable expense of the Company: 

  

	 	(d)	not to apply for the registration of any Company Intellectual Property in the United Kingdom or any other part of the world without the prior written consent of the Company; and 

 

	 	(e)	to keep confidential all Company Intellectual Property unless the Company has consented in writing to its disclosure by the Executive. 

 

	10.6	As against the Company, its successors and assigns and any licensee of any of the foregoing, the Executive hereby waives all of his present and future moral rights which arise under the Copyright Designs and Patents Act
1988 and all similar rights in other jurisdictions relating to the Company Intellectual Property. 

  

	10.7	The Executive acknowledges that, except as provided by law, no further remuneration or compensation, other than that provided for in this Agreement, is or may become due to the Executive in respect of his compliance
with this clause 10. This clause is without prejudice to the Executive’s rights under the Patents Act 1977. 

  

	10.8	The Executive irrevocably appoints the Company as the Executive’s attorney in the Executive’s name to sign, execute, do or deliver on the Executive’s behalf any deed, document or other instrument and to
use the Executive’s name for the purpose of giving full effect to this clause 10. 

  
 7 

	10.9	Rights and obligations under this Agreement shall continue in force after termination of this Agreement in respect of any Company Intellectual Property. 

 

	10.10  	In this Agreement words defined below shall have the following respective meanings: 

“Company Intellectual Property” means any and all Intellectual Property Rights created by the Executive (whether jointly or alone)
resulting from the Executive’s performance of the Development Duties, whether or not during working hours or using Company premises or resources and whether or not recorded in material form; 

“Intellectual Property Rights” means patents, Inventions, copyright and related rights, trade marks, trade names, service marks and
domain names, rights in get-up, goodwill, rights to sue for passing off, design rights, semi-conductor topography rights, database rights, confidential information, moral rights, proprietary rights and any
other intellectual property rights in each case whether registered or unregistered and including all applications or rights to apply for, and renewals or extensions of such rights and all similar or equivalent rights or forms of protection which
subsist or will subsist now or in the future in any part of the world; and 
 “Invention” means any invention, idea, discovery,
development, improvement or innovation, processes, formulae, models or prototypes, whether or not patentable or capable of registration, and whether or not recorded in any medium. 

 

	11.	RESTRICTIVE COVENANTS 

  

	11.1	Since the Executive will in the course of his employment hereunder have dealings with customers and obtain knowledge of the trade secrets and other confidential information in regard to the business of the Company and
its Associated Companies, the Executive hereby agrees and undertakes with the Company for itself and as trustee for its Associated Companies that he shall not without the prior written consent of the Board (such consent to be withheld only so far as
may be reasonably necessary to protect the legitimate interests of the Company or any Associated Company): 

  

	 	(a)	for a period of 12 months after the termination of his employment hereunder be engaged or interested (whether as a director, shareholder, principal, consultant, agent, partner or employee or otherwise) in any business
concern (of whatever kind) which shall in the United Kingdom be in competition with the Company or with any Associated Company in the provision of services relating to gene therapy or the manufacture, sale or supply of goods relating to gene
therapy, being services or goods of a kind with which the Executive was concerned to a material extent during the period of one year prior to the termination of his employment with the Company provided always that nothing in this clause
(a) shall restrain the Executive from engaging or being interested as aforesaid in any such business concern in so far as his duties or work relate principally to services or goods of a kind with which the Executive was not concerned during the
period of one year prior to the termination of his employment hereunder; 

  
 8 

	 	(b)	for a period of 12 months after the termination of his employment hereunder either on his own behalf or on behalf of any other person, firm or company in respect of any services of a kind provided relating to gene
therapies of a kind developed or licensed by the Company or any goods of a kind similar to or the same as those sold or supplied by the Company and/or any Associated Company relating to gene therapies of a kind developed or licensed by the Company
in respect of the provision or sale or supply of which the Executive may have been engaged during his employment with the Company or any Associated Company: 

  

	 	(i)	canvass, solicit or approach or cause to be canvassed, solicited or approached for orders; or 

  

	 	(ii)	directly or indirectly deal with any person, firm or company who at the date of the termination of this Agreement or within one year prior to such date is or was a client or customer of the Company or any Associated
Company or was in the habit of dealing under contract with the Company or any Associated Company and with whom or which the Executive had provided or arranged the provision of service or services on behalf of the Company or any Associated Company or
for whom the Executive had management responsibility or material contact with during the period of one year prior to the termination of this Agreement; and 

  

	 	(c)	for a period of 12 months after the termination of his employment hereunder either on his own behalf or on behalf of any other person, firm or company directly or indirectly solicit or entice or endeavour to solicit or
entice away from the Company or from any Associated Company any employee of executive or managerial status engaged in its or their business and with whom the Executive had dealings at any time during the last year of his employment hereunder.

  

	11.2	Whilst each of the restrictions in clauses 11.1(a), 11.1(b) and 11.1(c) are considered by the parties to be reasonable in all the circumstances as at the date hereof it is hereby agreed and declared that if any one or
more of such restrictions shall be judged to be void as going beyond what is reasonable in all the circumstances for the protection of the interests of the Company and/or any Associated Company but would be valid if words were deleted therefrom the
said restrictions shall be deemed to apply with such modifications as may be necessary to make them valid and effective and any such modification shall not thereby affect the validity of any other restriction contained herein. 

 

	12.	TERMINATION ON THE HAPPENING OF CERTAIN EVENTS 

  

	12.1	The Company reserves the right in its absolute discretion and at any time (including after notice of termination has been served by either party) to terminate the Executive’s employment with immediate effect by
notifying the Executive that it is exercising its rights under this clause and that within 28 days it will make a payment in lieu of the notice entitlement referred to in clause 1 or if less, any unexpired period of notice of termination. Such a
payment in lieu shall consist of a sum equivalent to the Executive’s annual salary only for the relevant period. 

  
 9 

	12.2	The Company without prejudice to any remedy which it may have against the Executive for the breach or non-performance of any of the provisions of this Agreement may forthwith
terminate this Agreement without notice or payment in lieu of notice if the Executive: 

  

	 	(a)	becomes bankrupt or become the subject of an interim order under the Insolvency Act 1986 or make any arrangement or composition with his creditors; or 

 

	 	(b)	becomes of unsound mind or a patient as defined in the Mental Health Act 1983; or 

  

	 	(c)	is convicted of any criminal offence (other than an offence under road traffic legislation in the United Kingdom or elsewhere for which a penalty other than imprisonment for three months or more is imposed); or

  

	 	(d)	commits any act of dishonesty, fraud or corruption whether relating to the Company, any Associated Company, other employees or otherwise; or 

 

	 	(e)	is prevented by illness or otherwise from performing his duties hereunder for a consecutive period of six calendar months or for an aggregate period of six calendar months in any period of 12 calendar months; or

  

	 	(f)	is guilty of any gross or serious misconduct, any conduct tending to bring the Company or himself into disrepute, or any material breach or non-observance of any of the provisions
of this Agreement or shall neglect, fail or refuse to carry out duties properly assigned to him hereunder. 

  

	13.	OBLIGATIONS UPON TERMINATION OF EMPLOYMENT 

  

	13.1	Upon the termination of his employment hereunder for whatever reason, or upon the Company’s exercise of its rights under clauses 13.1(a) and 13.1(b) at any time after notice of termination has been given under
clause 1, the Executive shall: 

  

	 	(a)	forthwith tender his resignation as a Director of the Company and of any Associated Company without compensation. To secure his obligation under this Agreement the Executive irrevocably appoints the Company to be his
attorney in his name and on his behalf to sign any documents and do any things necessary to give effect thereto, if the Executive shall fail to sign or do the same himself; 

	 	(b)	 deliver up to the Company all vehicles, keys, credit cards, correspondence, documents, specifications, reports,
papers and records (including any computer materials such as discs or tapes) and all copies thereof and any other property (whether or not similar to the foregoing or any of them) belonging to the Company or any Associated Company which may be in
his possession or under his control, 

  
 10 

	 	
and (unless prevented by the owner thereof) any such property belonging to others which may be in his possession or under his control and which relates in any way to the business or affairs of
the Company or any Associated Company or any supplier, agent, distributor or customer of the Company or any Associated Company, and he shall not without written consent of the Board retain any copies thereof; 

 

	 	(c)	if so requested send to the Company a signed statement confirming that he has complied with clause 13.1(b); and 

  

	 	(d)	not at any time represent himself still to be connected with the Company or any Associated Company. 

  

	14.	GARDEN LEAVE 

  

	14.1	Notwithstanding the provisions of clause 2.1, following the Company or the Executive giving notice to terminate the Executive’s employment or if the Executive purports to terminate his employment in breach of
contract, the Company may require the Executive not to perform any services (or to perform only specified services) for the Company or for any Associated Company for all or part of the applicable notice period required under clause 1.

  

	14.2	During any period where the Company exercises its rights under clause 14.1 above, the Executive shall: 

  

	 	(a)	continue to receive his salary and other contractual benefits under this Agreement in the usual way and subject to the terms of any benefit arrangements; 

 

	 	(b)	remain an employee of the Company and remain bound by his duties and obligations, whether under this Agreement or otherwise, which shall continue in full force and effect; 

 

	 	(c)	not contact or deal with (or attempt to contact or deal with) any customer client supplier agent distributor shareholder employee officer or other business contact of the Company or any Associated Company;

  

	 	(d)	not (unless otherwise requested) enter onto the premises of the Company or any Associated Company; 

  

	 	(e)	not commence any other employment or engagement (including taking up any directorships or consultancy services; 

  

	 	(f)	provide such reasonable assistance as the Company or any Associated Company may require to effect an orderly handover of his responsibilities to any individual or individuals appointed by the Company or any Associated
Company to take over his role or responsibilities; and 

  
 11 

	 	(g)	make himself reasonably available to deal with requests for information, to provide assistance, to attend meetings and to advise on matters relating to the Company’s business. 

 

	14.3	In the event that the Company exercises its rights under clause 14.1 above then any period of time this relates to shall be set off against and therefore reduce the periods for which the restrictions in clause 11.1 of
this Agreement apply. 

  

	15.	OTHER TERMS AND CONDITIONS 

  

	15.1	The following particulars are given in compliance with the requirements of s 1 Employment Rights Act 1996: 

  

	 	(a)	the Executive’s normal place of work is UCLB, 97 Tottenham Court Road, London W1T 4TP but he may be required to work at any other office or location in the UK as may be directed by the Board from time to time;

  

	 	(b)	the Executive’s continuous employment began on April 27th, 2015. No employment of the Executive with a previous employer counts as part of the Executive’s continuous employment with the Company;

  

	 	(c)	the Executive’s hours of work shall be the normal hours of work of the Company which are from [insert-time] am to [insert time] pm together with such
additional hours as may be necessary for the proper discharge of his duties hereunder to the satisfaction of the Board; 

  

	 	(d)	if the Executive is dissatisfied with any disciplinary decision or if he has any grievance relating to his employment hereunder he should refer such disciplinary decision or grievance to the Board and the reference will
be dealt with by discussion at and decision of a Board Meeting; 

  

	 	(e)	no contracting-out certificate pursuant to the provisions of Pension Schemes Act 1993 is in force in respect of the Executive’s employment hereunder; and 

 

	 	(f)	save as otherwise herein provided there are no terms or conditions of employment relating to hours of work or to normal working hours or to entitlement to holiday (including public holidays) or holiday pay or to
incapacity for work due to sickness or injury or to pensions or pension schemes and no collective agreement has any effect upon the Executive’s employment hereunder. 

 

	16.	DEFINITION 

 In this Agreement an “Associated Company” means any company
which for the time being is: 
  

	 	(a)	a parent undertaking (as defined by the Companies Act 2006) of the Company; or 

  
 12 

	 	(b)	any subsidiary undertaking (as defined by the Companies Act 2006) of any such parent company or of the Company. 

  

	17.	MISCELLANEOUS 

 A person, firm or company who or that is not a party to this Agreement
shall have no right under the Contracts (Rights of Third Parties) Act 1999 to enforce any term of this Agreement. 
  

	18.	APPLICABLE LAW 

 English law shall apply to this Agreement and the parties submit to the
jurisdiction of the English Courts. 

  
 13 

 IN WITNESS whereof this deed has been duly executed and delivered the day and year first before written

  

					
	Executed as a deed by	  	)	  	
		  	)	  	Athena Vision Limited
	acting by:	  	)	  	
			
	 /s/ Rich Giroux
	  		  	
	Director	  		  	
			
	 /s/ Tom Shenk
	  		  	
	Director Secretary	  		  	
			
	Sign as a deed by	  	)	  	
		  	)	  	RG
	In the presence of	  	)	  	
			
	 /s/ Sury Penny
	  		  	
	Witness’ signature	  		  	
			
	 Sury Penny
	  		  	
	Witness’ name	  		  	
			
	 Hogan Lovells International LLP
	  		  	
	 DX57
	  		  	
	 LONDON CHANCERY LANE
	  		  	
			
	Witness’ address	  		  	

  
 14

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]